Benzinga's M&A Chatter for Tuesday November 10, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday November 10, 2015: Molson Coors Close to Deal to Acquire Remaining MillerCoors Stake from SABmiller The Rumor:
Molson Coors Brewing Co TAP is said to be close to a deal to acquire the remainder of the MillerCoors LLC U.S. joint venture, as reported by The Wall Street Journal on Tuesday. SABMiller's SBMRY 58% stake in the venture would cost Molson Coors roguhly $12 billion, according to sources. That deal would clear the way for the acquisition of SABMiller by Anheuser-Busch InBev BUD. Moslon Coors shares rose 1 Tuesday, closing at $88.31. Morgan Stanley Note Mentions Intercept as Potential Takeover Target for Amgen The Analyst Note:
Intercept ICPT shares surged higher Tuesday, on a note from Morgan Stanley which mentioned it a possible takeover target for Amgen AMGN. A spokesperson for Intercept told Benzinga there was no other news to account for the move. Intercept shares rose as high as $217.99 on Tuesday, closing at $205.97, up 7%. Astellas to Acquire Ocata Therapeutics for $8.50/Share in Cash The Deal:
Astellas Pharma Inc. ALPMY and Ocata Therapeutics, Inc. OCAT announced Tuesday, that have agreed that Astellas will acquire Ocata through Astellas subsidiary Laurel Acquisition Inc., for $8.50 per share in cash. The acquisition will be made by way of tender offer. Ocata Therapeutics shares rose 89% Tuesday, closing at $8.44.